Kathleen M. Wyvill

An Interleukin‐6–Related Systemic Inflammatory Syndrome in Patients Co‐Infected with Kaposi Sarcoma–Associated Herpesvirus and HIV but without Multicentric Castleman Disease

Thomas S. Uldrick, Victoria Wang, Deirdre O’Mahony et al. · Clinical Infectious Diseases · 2010 · 306 citations · Full text

Activity of Thalidomide in AIDS-Related Kaposi’s Sarcoma

Richard F. Little, Kathleen M. Wyvill, James M. Pluda et al. · Journal of Clinical Oncology · 2000 · 290 citations

Primary Immunodeficiency, Median Thalidomide Dose, Oncology +12

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

Robert Yarchoan, James M. Pluda, Rose V. Thomas et al. · The Lancet · 1990 · 215 citations

Medicine, Immunology, Long-term Toxicity/activity Profile +6

Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS)

Mark N. Polizzotto, Thomas S. Uldrick, Kathleen M. Wyvill et al. · Clinical Infectious Diseases · 2015 · 213 citations · Full text

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.

Lauri Welles, M. Wayne Saville, Jill Lietzau et al. · Journal of Clinical Oncology · 1998 · 174 citations